Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Sep 29, 2023
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
- Prior Approval Requests for Revisions to an Approved Data Management and Sharing (DMS) Plan Must be Submitted Using the Prior Approval Module
(NOT-OD-23-185)
National Institutes of Health
General Notices
- Notice of Information: Recruitment and Retention Monitoring and Reporting of Clinical Research Awards Supported by the National Institute on Drug Abuse
(NOT-DA-23-033)
National Institute on Drug Abuse
- Solicitation of Nominations for the 2023 National Human Genome Research Institutes Bettie J. Graham Leadership Award for Enhancing Diversity, Equity, Inclusion, and Accessibility in the Genomics Workforce
(NOT-HG-24-003)
National Human Genome Research Institute
- NIH Subaward Requirements: Domestic and Foreign NIH Virtual Event - Tuesday, October 17, 2023
(NOT-OD-23-190)
National Institutes of Health
- Notice of Availability: Draft Scientific Integrity Policy of the National Institutes of Health
(NOT-OD-23-183)
Office of the Director, NIH
Notice of Changes to Funding Opportunities
- Notice of Change to Application Due Date for PAR-21-306 "NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)"
(NOT-CA-23-094)
National Cancer Institute
- Update to NIDDK Policy on Combined Support Between and Institutional Career Development Award and an Individual Career Development Award
(NOT-DK-23-025)
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Clarification to NIEHS' Participation on PA-23-189, "Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)"
(NOT-ES-23-015)
National Institute of Environmental Health Sciences
- Notice of NICHD Participation in NOT-OD-23-170 Research Supplements to Promote Re-entry, Re-integration into, and Re-training in Health-Related Research Careers (Admin Supp - Clinical Trial Not Allowed)
(NOT-HD-23-027)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice of NICHD Participation in PAR-23-285 Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)
(NOT-HD-23-028)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice of NICHD Participation in PAR-23-299 Research to Improve Native American Health (R21 Clinical Trials Optional)
(NOT-HD-23-029)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice of NICHD Participation in PAR-23-298 Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
(NOT-HD-23-030)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice of NICHD Participation in PAR-23-219, SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)
(NOT-HD-23-031)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice of NICHD Participation in PAR-23-220, SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)
(NOT-HD-23-032)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Notice of FY2024 Cohort Dates for PAR-22-073, Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)
(NOT-OD-23-188)
Office of the Director, NIH
- Notice to Extend the Expiration Date for PA-20-272 "Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)"
(NOT-OD-23-189)
National Institutes of Health
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for Microphysiological Systems to Advance Precision Medicine for AD/ADRD Treatment and Prevention (U54 Clinical Trial Not Allowed)
(NOT-AG-23-059)
National Institute on Aging
- Notice of Intent to Publish a Notice of Funding Opportunity for Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
(NOT-AT-24-014)
National Center for Complementary and Integrative Health
- Notice of Intent to Publish a Notice of Funding Opportunity for Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
(NOT-AT-24-015)
National Center for Complementary and Integrative Health
- Notice of Intent to Publish a Notice of Funding Opportunity for NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
(NOT-AT-24-016)
National Center for Complementary and Integrative Health
- Notice of Intent to Publish a Notice of Funding Opportunity for Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required)
(NOT-AT-24-017)
National Center for Complementary and Integrative Health
- Notice of Intent to Publish a Notice of Funding Opportunity for Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)
(NOT-AT-24-018)
National Center for Complementary and Integrative Health
- Notice of Intent to Publish a Notice of Funding Opportunity for NCCIH Natural Product Mid Phase Clinical Trial Cooperative Agreement (R01 Clinical Trial Required)
(NOT-AT-24-019)
National Center for Complementary and Integrative Health
- Notice of Intent to Publish a Notice of Funding Opportunity for NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
(NOT-AT-24-020)
National Center for Complementary and Integrative Health
- Notice of Intent to Publish a Notice of Funding Opportunity for Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
(NOT-AT-24-021)
National Center for Complementary and Integrative Health
- Notice of Intent to Publish a Notice of Funding Opportunity for NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
(NOT-AT-24-022)
National Center for Complementary and Integrative Health
- Notice of Intent to Publish a Notice of Funding Opportunity for Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required)
(NOT-AT-24-023)
National Center for Complementary and Integrative Health
- Notice of Intent to Publish a Notice of Funding Opportunity Announcement for Early Psychosis Intervention Network (EPINET): Learning Health Care Research to Improve Mental Health Services and Outcomes (P01 Clinical Trial Optional)
(NOT-MH-23-295)
National Institute of Mental Health
- Notice of Intent to Publish a Notice of Funding Opportunity for Early Psychosis Intervention Network (EPINET) Data Coordinating Center (U24 Clinical Trial Not Allowed)
(NOT-MH-23-296)
National Institute of Mental Health
- Notice of Intent to Publish a Funding Opportunity Announcement for Career Enhancement Awards to Advance Research on Firearm Injury and Mortality Prevention
(NOT-OD-23-192)
Office of Behavioral and Social Sciences Research
Notices of Special Interest
- Notice of Special Interest (NOSI): Ending the HIV Epidemic (EHE)
(NOT-AI-23-070)
National Institute of Allergy and Infectious Diseases
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Nursing Research
Office of AIDS Research
Funding Opportunities
- Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed)
(PAR-23-276)
National Cancer Institute - Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)
(PAR-23-277)
National Cancer Institute - Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed)
(PAR-23-278)
National Cancer Institute - Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
(PAR-23-301)
National Human Genome Research Institute - Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
(PAR-23-302)
National Human Genome Research Institute - Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional)
(PAR-23-309)
National Institute on Minority Health and Health Disparities
National Cancer Institute
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
Office of Behavioral and Social Sciences Research - Fc-Dependent Mechanisms of Antibody-Mediated Killing (R01 Clinical Trial Not Allowed)
(RFA-AI-23-054)
National Institute of Allergy and Infectious Diseases - Mechanistic Studies of the Effects of Psychosocial Stress on Complex Morbidity Involving SUD, Psychiatric Disorders, and HIV (R01 Clinical Trials Optional)
(RFA-DA-24-005)
National Institute on Drug Abuse - Mechanistic Studies of the Effects of Psychosocial Stress on Complex Morbidity Involving SUD, Psychiatric Disorders, and HIV (R01 Basic Experimental Studies with Humans (BESH) Required)
(RFA-DA-24-006)
National Institute on Drug Abuse - Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Clinical Trial Optional)
(RFA-DA-24-031)
National Institute on Drug Abuse - Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Basic Experimental Studies with Humans Required)
(RFA-DA-24-032)
National Institute on Drug Abuse - Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Clinical Trial Optional)
(RFA-DA-24-033)
National Institute on Drug Abuse - Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional)
(RFA-DA-25-047)
National Institute on Drug Abuse - Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional)
(RFA-DA-25-048)
National Institute on Drug Abuse - NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed)
(RFA-DE-24-006)
National Institute of Dental and Craniofacial Research - Interventions to Address HIV-Related Comorbidities among Highly Affected Populations Experiencing Health Disparities (R01 - Clinical Trial Required)
(RFA-MD-24-003)
National Institute on Minority Health and Health Disparities
Office of Research on Women's Health - Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional)
(RFA-NS-23-032)
National Institute of Neurological Disorders and Stroke
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu(link sends e-mail)(link sends e-mail) or 313-335-2123, or email Ann Ricketts at ann-ricketts@uiowa.edu(link sends e-mail)(link sends e-mail) or Lynn Hudachek at lynn-hudachek@uiowa.edu(link sends e-mail)(link sends e-mail).
